Huai'an First People's Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.hasyy.cn

Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma

Phase 2
Recruiting
Conditions
Interventions
First Posted Date
2024-08-22
Last Posted Date
2024-08-22
Lead Sponsor
Huai'an First People's Hospital
Target Recruit Count
51
Registration Number
NCT06566807
Locations
🇨🇳

The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University#Huai'an First People's Hospital#, Huai'an,, Jiangsu, China

A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL

First Posted Date
2024-06-06
Last Posted Date
2024-06-06
Lead Sponsor
Huai'an First People's Hospital
Target Recruit Count
30
Registration Number
NCT06445257
Locations
🇨🇳

The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University(Huai'an First People's Hospital), Huai'an, Jiangsu, China

Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.

First Posted Date
2024-03-25
Last Posted Date
2024-03-25
Lead Sponsor
Huai'an First People's Hospital
Target Recruit Count
34
Registration Number
NCT06328179
Locations
🇨🇳

The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University(Huai'an First People's Hospital), Huai'an, Jiangsu, China

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

First Posted Date
2018-07-26
Last Posted Date
2024-01-09
Lead Sponsor
Huai'an First People's Hospital
Target Recruit Count
434
Registration Number
NCT03600831
Locations
🇨🇳

Huai'an second peiple's Hospital, Huai'an, Jiangsu, China

🇨🇳

Lianshui County Peoples Hospital, Huai'an, Jiangsu, China

🇨🇳

xuyi peiple's Hospital, Xu Yi, Jiangsu, China

and more 1 locations

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

First Posted Date
2018-07-13
Last Posted Date
2021-04-06
Lead Sponsor
Huai'an First People's Hospital
Target Recruit Count
32
Registration Number
NCT03585530
Locations
🇨🇳

Huai'an First Hospital, Huai'an, Jiangsu, China

Study of Apatinib in Metastatic Esophageal Cancer

Phase 2
Conditions
Interventions
First Posted Date
2016-02-17
Last Posted Date
2016-02-17
Lead Sponsor
Huai'an First People's Hospital
Target Recruit Count
40
Registration Number
NCT02683655
Locations
🇨🇳

Huaian First People's Hospital, Huaian, Jiangsu, China

© Copyright 2024. All Rights Reserved by MedPath